drugset / Trial / NCT00359112

AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes

NCT00359112

Phase 3 Completed 544 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

This study compares the effects of Avandamet (rosiglitazone maleate/metformin) treatment and metformin plus sulphonylurea treatment in overweight people with type 2 diabetes.

Timeline

Start
2004-02
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosiglitazone Small molecule
Background Metformin Small molecule